Edition:
India

EyePoint Pharmaceuticals Inc (EYPT.OQ)

EYPT.OQ on NASDAQ Stock Exchange Global Market

1.51USD
1:30am IST
Change (% chg)

$0.07 (+4.86%)
Prev Close
$1.44
Open
$1.47
Day's High
$1.52
Day's Low
$1.44
Volume
60,934
Avg. Vol
115,776
52-wk High
$3.94
52-wk Low
$1.20

About

Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug delivery products primarily for the treatment of chronic eye diseases. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 39.32
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates